Immatics (IMTX) News Today $5.42 +0.15 (+2.85%) Closing price 02/4/2025 04:00 PM EasternExtended Trading$5.42 0.00 (0.00%) As of 02/4/2025 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Immatics (NASDAQ:IMTX) Reaches New 1-Year Low - What's Next?Immatics (NASDAQ:IMTX) Reaches New 12-Month Low - Should You Sell?February 4 at 5:34 AM | marketbeat.comImmatics (NASDAQ:IMTX) Short Interest Up 13.1% in JanuaryImmatics (NASDAQ:IMTX - Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 9,570,000 shares, a growth of 13.1% from the December 31st total of 8,460,000 shares. Based on an average daily trading volume, of 772,000 shares, the days-to-cover ratio is presently 12.4 days.February 3 at 1:34 PM | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Should You Sell?Immatics (NASDAQ:IMTX) Hits New 1-Year Low - Here's What HappenedJanuary 29, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Reaches New 52-Week Low - Time to Sell?Immatics (NASDAQ:IMTX) Hits New 1-Year Low - Here's WhyJanuary 22, 2025 | marketbeat.comAnalysts Offer Predictions for Immatics FY2025 EarningsImmatics (NASDAQ:IMTX - Free Report) - Investment analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Immatics in a research report issued on Tuesday, January 21st. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will earn ($1.34) per share for the yearJanuary 22, 2025 | marketbeat.comIs Immatics N.V. (IMTX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?January 20, 2025 | insidermonkey.comImmatics (NASDAQ:IMTX) Sees Significant Increase in Short InterestImmatics (NASDAQ:IMTX - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 9,570,000 shares, an increase of 13.1% from the December 15th total of 8,460,000 shares. Based on an average daily trading volume, of 772,000 shares, the short-interest ratio is currently 12.4 days.January 18, 2025 | marketbeat.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Time to Sell?Immatics (NASDAQ:IMTX) Hits New 52-Week Low - Should You Sell?January 16, 2025 | marketbeat.comDown -16.85% in 4 Weeks, Here's Why Immatics (IMTX) Looks Ripe for a TurnaroundJanuary 16, 2025 | msn.comImmatics (NASDAQ:IMTX) Shares Down 3.9% - What's Next?Immatics (NASDAQ:IMTX) Trading Down 3.9% - Here's What HappenedJanuary 15, 2025 | marketbeat.comImmatics Advances PRAME Cell Therapy and Expands Oncology PipelineJanuary 13, 2025 | tipranks.comImmatics N.V.: Considering More Engineered T Cells For CancerJanuary 12, 2025 | seekingalpha.comImmatics (NASDAQ:IMTX) Sets New 12-Month Low - Here's WhyImmatics (NASDAQ:IMTX) Hits New 12-Month Low - Here's WhyJanuary 10, 2025 | marketbeat.comImmatics price target lowered to $13 from $15 at BofAJanuary 8, 2025 | markets.businessinsider.comImmatics (NASDAQ:IMTX) Sets New 1-Year Low - Should You Sell?Immatics (NASDAQ:IMTX) Sets New 52-Week Low - Time to Sell?December 18, 2024 | marketbeat.comImmatics (NASDAQ:IMTX) Short Interest UpdateImmatics (NASDAQ:IMTX - Get Free Report) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 8,190,000 shares, a growth of 6.4% from the November 15th total of 7,700,000 shares. Based on an average daily trading volume, of 596,800 shares, the short-interest ratio is presently 13.7 days.December 17, 2024 | marketbeat.comMizuho Securities Sticks to Its Buy Rating for Immatics (IMTX)December 16, 2024 | markets.businessinsider.comImmatics Faces Termination of Key Collaboration with Bristol Myers SquibbDecember 13, 2024 | tipranks.comImmatics (NASDAQ:IMTX) Stock Price Down 4.2% - Time to Sell?Immatics (NASDAQ:IMTX) Stock Price Down 4.2% - Should You Sell?December 13, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Has $15.46 Million Stake in Immatics (NASDAQ:IMTX)Frazier Life Sciences Management L.P. increased its holdings in shares of Immatics (NASDAQ:IMTX - Free Report) by 17.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,354,711 shares of the company's stock after acquiriDecember 10, 2024 | marketbeat.comImmatics (NASDAQ:IMTX) Holdings Lifted by Wellington Management Group LLPWellington Management Group LLP boosted its holdings in shares of Immatics (NASDAQ:IMTX - Free Report) by 1.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,681,183 shares of the company's stock after buying an additionDecember 10, 2024 | marketbeat.comWhy Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?December 5, 2024 | msn.comWalleye Capital LLC Sells 137,200 Shares of Immatics (NASDAQ:IMTX)Walleye Capital LLC trimmed its holdings in Immatics (NASDAQ:IMTX - Free Report) by 32.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 282,193 shares of the company's stock after selling 137,200 shares during the quarterDecember 3, 2024 | marketbeat.comBraidwell LP Takes $18.80 Million Position in Immatics (NASDAQ:IMTX)Braidwell LP acquired a new stake in shares of Immatics (NASDAQ:IMTX - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,647,565 shares of the company's stock, valued at approximately $18,799,00November 29, 2024 | marketbeat.comImmatics (NASDAQ:IMTX) is Vestal Point Capital LP's 9th Largest PositionVestal Point Capital LP increased its position in shares of Immatics (NASDAQ:IMTX - Free Report) by 36.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,750,000 shares of the company's stock after purchasing an additional 1,000,000November 29, 2024 | marketbeat.comImmatics (NASDAQ:IMTX) Upgraded by The Goldman Sachs Group to "Strong-Buy" RatingThe Goldman Sachs Group upgraded shares of Immatics to a "strong-buy" rating in a research report on Monday.November 28, 2024 | marketbeat.comImmatics moved to Buy from Not Rated at Goldman SachsNovember 28, 2024 | markets.businessinsider.comImmatics N.V. Reports Strong Q3 2024 Progress and FinancialsNovember 26, 2024 | markets.businessinsider.comImmatics: Promising Pipeline and Financial Health Justify Buy RatingNovember 25, 2024 | markets.businessinsider.comCantor Fitzgerald Forecasts Higher Earnings for ImmaticsImmatics (NASDAQ:IMTX - Free Report) - Equities researchers at Cantor Fitzgerald raised their FY2024 earnings per share estimates for Immatics in a report issued on Tuesday, November 19th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the company will post earnings of ($0.68) per sharNovember 22, 2024 | marketbeat.comFY2024 EPS Estimates for Immatics Raised by Leerink PartnrsImmatics (NASDAQ:IMTX - Free Report) - Investment analysts at Leerink Partnrs upped their FY2024 earnings per share estimates for shares of Immatics in a research report issued to clients and investors on Monday, November 18th. Leerink Partnrs analyst J. Chang now forecasts that the company willNovember 21, 2024 | marketbeat.comImmatics N.V. (NASDAQ:IMTX) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesNovember 20, 2024 | finance.yahoo.comImmatics price target lowered to $15 from $16 at BofANovember 20, 2024 | markets.businessinsider.comJefferies Releases a Buy Rating on Immatics (IMTX)November 20, 2024 | markets.businessinsider.comIs Immatics N.V. (IMTX) the Best German Stock to Buy Now?November 20, 2024 | msn.comImmatics (NASDAQ:IMTX) Price Target Cut to $15.00 by Analysts at Bank of AmericaBank of America lowered their price target on Immatics from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday.November 19, 2024 | marketbeat.comImmatics price target lowered to $18 from $19 at LeerinkNovember 18, 2024 | markets.businessinsider.comImmatics Sees Revenue Surge Despite R&D ExpensesNovember 18, 2024 | markets.businessinsider.comImmatics announces clinical data on TCER IMA402 targeting PRAMENovember 18, 2024 | markets.businessinsider.comImmatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAMENovember 18, 2024 | globenewswire.comImmatics (NASDAQ:IMTX) Reaches New 1-Year Low - Here's WhyImmatics (NASDAQ:IMTX) Reaches New 52-Week Low - Here's What HappenedNovember 14, 2024 | marketbeat.comImmatics’ Promising Immunotherapy Developments Bolster Jonathan Chang’s Buy RatingNovember 13, 2024 | markets.businessinsider.comImmatics Unveils Promising TCR-T Therapy DevelopmentsNovember 9, 2024 | markets.businessinsider.comImmatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAMENovember 8, 2024 | globenewswire.comPositive Outlook for Immatics Due to Promising Clinical Trial Results and Manageable Safety ProfilesNovember 7, 2024 | markets.businessinsider.comabrdn plc Invests $2.66 Million in Immatics (NASDAQ:IMTX)abrdn plc purchased a new position in Immatics (NASDAQ:IMTX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 232,900 shares of the company's stock, valued at approxNovember 4, 2024 | marketbeat.comImmatics N.V. (IMTX)October 26, 2024 | finance.yahoo.comImmatics N.V. (NASDAQ:IMTX) is a favorite amongst institutional investors who own 50%October 24, 2024 | finance.yahoo.comPerceptive Advisors LLC Reduces Stake in Immatics NVOctober 18, 2024 | finance.yahoo.comBuy Rating Affirmed for Immatics Amidst Promising Clinical Trials and Strategic Positioning in TCR TherapeuticsOctober 15, 2024 | markets.businessinsider.com Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address IMTX Media Mentions By Week IMTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMTX News Sentiment▼-0.030.44▲Average Medical News Sentiment IMTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMTX Articles This Week▼32▲IMTX Articles Average Week Get Immatics News Delivered to You Automatically Sign up to receive the latest news and ratings for IMTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kymera Therapeutics News Today Gemini Therapeutics News Today Arrowhead Pharmaceuticals News Today Mirum Pharmaceuticals News Today Vera Therapeutics News Today HUTCHMED News Today CG Oncology News Today ImmunityBio News Today Centessa Pharmaceuticals News Today Protagonist Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMTX) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. Share Immatics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMTX Stock Alerts